Patents Assigned to Bamboo Therapeutics, Inc.
  • Optimized mini-dystrophin genes and expression cassettes and their use
    Patent number: 12257321
    Abstract: This invention relates to polynucleotides encoding mini-dystrophin proteins, viral vectors comprising the same, and methods of using the same for delivery of mini-dystrophin to a cell or a subject.
    Type: Grant
    Filed: January 5, 2023
    Date of Patent: March 25, 2025
    Assignees: The University of North Carolina at Chapel Hill, Bamboo Therapeutics, Inc.
    Inventors: Xiao Xiao, Juan Li, Chunping Qiao, Scott W. J. McPhee, Richard J. Samulski, Maritza McIntyre
  • Optimized mini-dystrophin genes and expression cassettes and their use
    Patent number: 11547765
    Abstract: This invention relates to polynucleotides encoding mini-dystrophin proteins, viral vectors comprising the same, and methods of using the same for delivery of mini-dystrophin to a cell or a subject.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: January 10, 2023
    Assignees: The University of North Carolina at Chapel Hill, Bamboo Therapeutics, Inc.
    Inventors: Xiao Xiao, Juan Li, Chunping Qiao, Scott W. J. McPhee, Richard J. Samulski, Maritza McIntyre
  • Modified Friedreich ataxia genes and vectors for gene therapy
    Patent number: 10548947
    Abstract: The present invention relates to a modified FXN gene providing for increased expression of the encoded protein frataxin that can be used for treatment of Friedreich ataxia.
    Type: Grant
    Filed: November 1, 2016
    Date of Patent: February 4, 2020
    Assignee: Bamboo Therapeutics, Inc.
    Inventor: Richard J. Samulski